Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Bandages × Clear all

Phase

Phase NA 4 Phase 3 1 Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cisplatin 890 Cyclophosphamide 841 Carboplatin 838 Radiotherapy 781 Bevacizumab 737 Gemcitabine 708 pembrolizumab 657 Docetaxel 654 Paclitaxel 646 Oxaliplatin 611 Capecitabine 570 Fluorouracil 512 Rituximab 498 Nivolumab 440 Dexamethasone 432 Etoposide 411 Doxorubicin 398 Irinotecan 392 Leucovorin 338 Drug Therapy 336 Cytarabine 301 Cetuximab 295 Lenalidomide 288 Trastuzumab 282 Pemetrexed 279 durvalumab 262 Filgrastim 250 Magnetic Resonance Spectroscopy 239 Prednisone 237 Temozolomide 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07048184 2025-07-09

SUNDIAL

NHS Greater Glasgow and Clyde

Phase 2 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡